Cargando…

Optimal vaccination strategy for dengue transmission in Kupang city, Indonesia

Dengue is a public health problem with around 390 million cases annually and is caused by four distinct serotypes. Infection by one of the serotypes provides lifelong immunity to that serotype but have a higher chance of attracting the more dangerous forms of dengue in subsequent infections. Therefo...

Descripción completa

Detalles Bibliográficos
Autores principales: Ndii, Meksianis Z., Mage, Ananda R., Messakh, Jakobis J., Djahi, Bertha S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648192/
https://www.ncbi.nlm.nih.gov/pubmed/33204872
http://dx.doi.org/10.1016/j.heliyon.2020.e05345
_version_ 1783607064690425856
author Ndii, Meksianis Z.
Mage, Ananda R.
Messakh, Jakobis J.
Djahi, Bertha S.
author_facet Ndii, Meksianis Z.
Mage, Ananda R.
Messakh, Jakobis J.
Djahi, Bertha S.
author_sort Ndii, Meksianis Z.
collection PubMed
description Dengue is a public health problem with around 390 million cases annually and is caused by four distinct serotypes. Infection by one of the serotypes provides lifelong immunity to that serotype but have a higher chance of attracting the more dangerous forms of dengue in subsequent infections. Therefore, a perfect strategy against dengue is required. Dengue vaccine with 42-80% efficacy level has been licensed for the use in reducing disease transmission. However, this may increase the likelihood of obtaining the dangerous forms of dengue. In this paper, we have developed single and two-serotype dengue mathematical models to investigate the effects of vaccination on dengue transmission dynamics. The model is validated against dengue data from Kupang city, Indonesia. We investigate the effects of vaccination on seronegative and seropositive individuals and perform a global sensitivity analysis to determine the most influential parameters of the model. A sensitivity analysis suggests that the vaccination rate, the transmission probability and the biting rate have greater effects on the reduction of the proportion of dengue cases. Interestingly, with vaccine implementation, the mosquito-related parameters do not have significant impact on the reduction in the proportion of dengue cases. If the vaccination is implemented on seronegative individuals only, it may increase the likelihood of obtaining the severe dengue. To reduce the proportion of severe dengue cases, it is better to vaccinate seropositive individuals. In the context of Kupang City where the majority of individuals have been infected by at least one dengue serotype, the implementation of vaccination strategy is possible. However, understanding the serotype-specific differences is required to optimise the delivery of the intervention.
format Online
Article
Text
id pubmed-7648192
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-76481922020-11-16 Optimal vaccination strategy for dengue transmission in Kupang city, Indonesia Ndii, Meksianis Z. Mage, Ananda R. Messakh, Jakobis J. Djahi, Bertha S. Heliyon Research Article Dengue is a public health problem with around 390 million cases annually and is caused by four distinct serotypes. Infection by one of the serotypes provides lifelong immunity to that serotype but have a higher chance of attracting the more dangerous forms of dengue in subsequent infections. Therefore, a perfect strategy against dengue is required. Dengue vaccine with 42-80% efficacy level has been licensed for the use in reducing disease transmission. However, this may increase the likelihood of obtaining the dangerous forms of dengue. In this paper, we have developed single and two-serotype dengue mathematical models to investigate the effects of vaccination on dengue transmission dynamics. The model is validated against dengue data from Kupang city, Indonesia. We investigate the effects of vaccination on seronegative and seropositive individuals and perform a global sensitivity analysis to determine the most influential parameters of the model. A sensitivity analysis suggests that the vaccination rate, the transmission probability and the biting rate have greater effects on the reduction of the proportion of dengue cases. Interestingly, with vaccine implementation, the mosquito-related parameters do not have significant impact on the reduction in the proportion of dengue cases. If the vaccination is implemented on seronegative individuals only, it may increase the likelihood of obtaining the severe dengue. To reduce the proportion of severe dengue cases, it is better to vaccinate seropositive individuals. In the context of Kupang City where the majority of individuals have been infected by at least one dengue serotype, the implementation of vaccination strategy is possible. However, understanding the serotype-specific differences is required to optimise the delivery of the intervention. Elsevier 2020-11-04 /pmc/articles/PMC7648192/ /pubmed/33204872 http://dx.doi.org/10.1016/j.heliyon.2020.e05345 Text en © 2020 The Author(s) http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Research Article
Ndii, Meksianis Z.
Mage, Ananda R.
Messakh, Jakobis J.
Djahi, Bertha S.
Optimal vaccination strategy for dengue transmission in Kupang city, Indonesia
title Optimal vaccination strategy for dengue transmission in Kupang city, Indonesia
title_full Optimal vaccination strategy for dengue transmission in Kupang city, Indonesia
title_fullStr Optimal vaccination strategy for dengue transmission in Kupang city, Indonesia
title_full_unstemmed Optimal vaccination strategy for dengue transmission in Kupang city, Indonesia
title_short Optimal vaccination strategy for dengue transmission in Kupang city, Indonesia
title_sort optimal vaccination strategy for dengue transmission in kupang city, indonesia
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648192/
https://www.ncbi.nlm.nih.gov/pubmed/33204872
http://dx.doi.org/10.1016/j.heliyon.2020.e05345
work_keys_str_mv AT ndiimeksianisz optimalvaccinationstrategyfordenguetransmissioninkupangcityindonesia
AT mageanandar optimalvaccinationstrategyfordenguetransmissioninkupangcityindonesia
AT messakhjakobisj optimalvaccinationstrategyfordenguetransmissioninkupangcityindonesia
AT djahiberthas optimalvaccinationstrategyfordenguetransmissioninkupangcityindonesia